Professor Liam M Grover BMedSc(Hons), PhD, FIMMM

Professor Liam Grover

School of Chemical Engineering
Professor in Biomaterials Science
Deputy Head of School
Director of the Healthcare Technologies Institute (HTI)

Contact details

Healthcare Technologies Institute
3rd Floor, Institute of Translational Medicine
Heritage Building (Old Queen Elizabeth Hospital)
Mindelsohn Way
Edgbaston, Birmingham
B15 2TH

Professor Liam Grover is a Professor in Biomaterials Science and the Director of the Healthcare Technologies Institute.

Professor Grover is a materials scientist by training, and completed his PhD at the University of Birmingham before moving to McGill University (Montreal) to work as a CIHR skeletal health scholar. He returned to Birmingham in 2006 to establish a research group within the School of Chemical Engineering.

He has published widely on the development of new materials to replace the function of tissues (more than 180 papers) and has filed more than ten patents to protect technologies that range from osteogenic cements through to scar reducing dressings. He has given well over 50 invited talks outside the UK.  Since starting his career, he has moved three technologies from concept through to clinical trial.  

Since returning to Birmingham, he has raised over £30m to fund his research on the development and translation of novel medical technologies (EPSRC, MRC, BBSRC, ERDF, EU, NC3Rs, NSFC – China, NIHR, RCDM, and industry) and is the Founder-Director of the Healthcare Technologies Institute, which works to help move novel technologies through the translational pipeline.  He sits on the EPSRC Healthcare Technologies SAT, the NIHR i4i panel and has sat on the MRC DPFS panel.

He was the youngest Professor in the history of the University of Birmingham (32) and the youngest ever Fellow of the Institute of Materials (30). 


  • PGCert in learning and teaching in higher education, 2011
  • PhD in Dentistry, School of Dentistry, University of Birmingham, 2004
  • BMedSc(Hons), Biomedical Materials Science, University of Birmingham, 2001


Professor Grover has a PGCert in teaching in further education, his current teaching responsibilities include:

  •  Module coordinator and principle lecturer on Bioscience for Engineers (Level H and Level M)
  •  Coordinator for Bioscience for Engineers practical week.
  •  Module coordinator and principle lecturer on Modern Genome Based Bioscience/Frontier Interdisciplinary Bioscience (Level M)
  •  Module coordinator for MSc summer research projects (Level M)
  •  Lecturer on Sustainable Development module (Level H)

He has also given lectures at Keele University, the University of Wuerzburg and has been invited to lecture at the Technical University of Vienna.

Postgraduate supervision

Liam Grover’s research focuses on the development and characterisation of materials for the regeneration of diseased and damaged tissues, particularly bone and bone-interfacing tissues, but he has also published on the delivery of fibroblasts and keratinocytes for skin regeneration. Within this broader field, four of his principal areas of current research activity are:

Regenerating the hard-soft tissue interface: developing bone-to-bone ligament replacements using fibrin and ceramics; reinforcing ligament replacements

Polymer gel-encapsulation of cells: evaluating how cell encapsulation affects the mechanical properties of hydrogels; hydrogel matrices; cell responses to encapsulation; ultrasonic enhancement of matrix production

Calcium phosphate materials chemistry: involvement of amorphous materials in biomineralisation; developing calcium phosphate cement formulations

Controlling mineralisation: use of cheap proteins to adjust crystal habitats in industrial materials; stabilisation of amorphous minerals


Recent publications


Finlay, M, Hill, LA, Neag, G, Patel, B, Chipara, M, Lamont, HC, Frost, K, Patrick, K, Lewis, JW, Nicholson, T, Edwards, J, Jones, SW, Grover, L & Naylor, AJ 2023, 'A detailed methodology for the long-term in vitro culture and analysis of three-dimensional, self-structuring bone models generated from cell lines or primary osteoblastic cell populations [version 1; peer review: awaiting peer review]', F1000Research.

Senior, JJ, Moakes, R, Cooke, ME, Moxon, S, Smith, AM & Grover, L 2023, 'Agarose Fluid Gels Formed by Shear Processing During Gelation for Suspended 3D Bioprinting', Journal of visualized experiments : JoVE, vol. 195, e64458.

Knowles, HJ, Chanalaris, A, Koutsikouni, A, Cribbs, AP, Grover, LM & Hulley, PA 2023, 'Mature primary human osteocytes in mini organotypic cultures secrete FGF23 and PTH1-34-regulated sclerostin', Frontiers in Endocrinology, vol. 14, 1167734.

Robinson, TE, Brunet, MY, Chapple, I, Heagerty, AHM, Metcalfe, AD & Grover, LM 2023, 'Self‐Delivering Microstructured Iota Carrageenan Spray Inhibits Fibrosis at Multiple Length Scales', Advanced NanoBiomed Research, vol. 3, no. 9, 2300048.

Sui, C, Robinson, TE, Williams, RL, Eisenstein, NM & Grover, LM 2023, 'Triggered metabolism of adenosine triphosphate as an explanation for the chemical heterogeneity of heterotopic ossification', Communications Chemistry, vol. 6, no. 1, 227.

Moetazedian, A, Candeo, A, Liu, S, Hughes, A, Nasrollahi, V, Saadat, M, Bassi, A, Grover, LM, Cox, LR & Poologasundarampillai, G 2023, 'Versatile Microfluidics for Biofabrication Platforms Enabled by an Agile and Inexpensive Fabrication Pipeline', Advanced Healthcare Materials.

Carter, L, Villapun, V, Grover, L & Cox, S 2022, 'Exploring the duality of powder adhesion and underlying surface roughness in laser powder bed fusion processed Ti-6Al-4V', Journal of Manufacturing Processes, vol. 81, pp. 14-26.

M grover, L, Moakes, R & Rauz, S 2022, 'Innovations in fluid-gel eye drops for treating disease of the eye: prospects for enhancing drug retention and reducing corneal scarring', Expert Review of Ophthalmology, vol. 17, no. 3, pp. 175-181.

Cao, X, Carter, L, Villapun, VM, Cantaboni, F, De Sio, G, Lowther, M, Louth, S, Grover, L, Ginestra, P & Cox, S 2022, 'Optimisation of single contour strategy in selective laser melting of Ti-6Al-4V lattices', Rapid Prototyping Journal, vol. 28, no. 5, pp. 907-915.

Bassett, DC, Robinson, TE, Hill, RJ, Grover, LM & Barralet, JE 2022, 'Self-assembled calcium pyrophosphate nanostructures for targeted molecular delivery', Biomaterials advances, vol. 140, 213086.

Villapun Puzas, VM, Carter, LN, Schröder, C, Colavita, PE, Hoey, DA, Webber, MA, Addison, O, Shepherd, DET, Attallah, MM, Grover, LM & Cox, SC 2022, 'Surface Free Energy Dominates the Biological Interactions of Postprocessed Additively Manufactured Ti-6Al-4V', ACS Biomaterial Science and Engineering, vol. 8, no. 10, pp. 4311-4326.

Carter, L, Reed, C, Morrell, A, Fong, AKH, Chowdhury, R, Miller, E, Alberini, F, Khambay, B, Anand, S, Grover, L, Coward, T, Addison, O & Cox, S 2021, 'A feasible route for the design and manufacture of customised respiratory protection through digital facial capture', Scientific Reports, vol. 11, no. 1, 21449.

Review article

Latham, S, Williams, R, Grover, L & Rauz, S 2023, 'Achieving net-zero in the dry eye disease care pathway', Eye.

Lewns, FK, Tsigkou, O, Cox, LR, Wildman, RD, Grover, LM & Poologasundarampillai, G 2023, 'Hydrogels and Bioprinting in Bone Tissue Engineering: Creating Artificial Stem-Cell Niches for In Vitro Models', Advanced Materials.

Moakes, RJA, Grover, LM & Robinson, TE 2022, 'Can We Structure Biomaterials to Spray Well Whilst Maintaining Functionality?', Bioengineering (Basel, Switzerland), vol. 10, no. 1, 3.

View all publications in research portal


Tissue regeneration; new implant materials; growth of tissue in the lab that could be implanted or used as a biological model to study factors that may influence tissues in the body.


Tissue regeneration; new implant materials; growth of tissue in the lab that could be implanted or used as a biological model to study factors that may influence tissues in the body.